Intels, Billion

Intel's $20 Billion Foundry Bet: The Market Is Demanding Proof, Not Promises

Published on 07/31/2026 at 17:42 | Redaktion boerse-global.de

Intel's stock surges 374% in a year but drops 25% in 30 days as $20B capex and thin external foundry revenue raise concerns.

Intel Stock: Turnaround Costs and Foundry Risks Test Investor Patience
Intel's $20 Billion Foundry Bet: The Market Is Demanding Proof, Not Promises Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

The arithmetic of Intel's turnaround has never been more uncomfortable. The stock has gained roughly 365 percent over the past twelve months, yet in the last 30 days it has shed more than a quarter of its value. That tension — between genuine operational progress and the escalating cost of achieving it — now defines the investment case.

At 80.91 euros, the shares sit 18 percent below their 50-day average of 98.70 euros. The recent session saw a four percent bounce to 82.40 euros, but that did little to mask the underlying pattern: a violent consolidation within an otherwise extraordinary re-rating. From the start of the year, the stock remains up 162 percent, and the twelve-month gain stands at 374 percent. The current turbulence looks less like a breakdown and more like a sharp recalibration of expectations.

The Price of Ambition

The core issue is capital intensity. Management has lifted its 2026 investment target to more than $20 billion, with the bulk directed toward expanding fabrication plants in Arizona and Ireland. That spending plan arrives at an awkward moment: external customers still account for only a sliver of foundry revenue, leaving Intel as its own primary client. Until third-party orders arrive at scale, the capital burden is difficult to justify.

The second-quarter numbers, however, tell a story of genuine momentum. Revenue grew 25 percent year over year — the fastest pace in nearly 15 years — and beat analyst expectations for the second consecutive quarter. The foundry segment posted revenue of $5.8 billion, up six percent quarter over quarter and 31 percent year over year, with gross margins improving on higher volumes and a better product mix.

Should investors sell immediately? Or is it worth buying Intel?

Yet the market's reaction was anything but linear. Initial enthusiasm gave way to renewed caution once investors focused on the thinness of the external customer base and the pace of AI-related progress. That whiplash within a single trading session helps explain why the annualized 30-day volatility sits near 80 percent. This is not a quiet long-term holding; it is a stock in the middle of a high-stakes transition.

A Milestone With Limits

The most concrete validation of the foundry strategy came with the disclosure that Fortinet will manufacture its next security chip at Intel's Fab 34 in Ireland, using the older Intel-4 process. It marks the first time a company has publicly committed a forthcoming product to Intel's manufacturing — a symbolic breakthrough that could ease future customer conversations.

But the caveats weigh as heavily as the achievement. The Fortinet chip runs on a less advanced node, not the cutting-edge 18A technology on which Intel's entire thesis depends. External foundry revenue reached $293 million in the quarter, up from $174 million previously, yet that still represents only about five percent of segment sales. The segment posted a $2.1 billion loss. The flagship 18A business remains largely unproven with outside customers, despite raised guidance and escalating investment.

The Road Ahead

Technically, Intel has reached an important milestone: the 18A process is now in mass production, powering the new Panther Lake processors. Management has also pulled forward the timeline for the next node, 14A, with mass production now slated for 2028 — a year ahead of schedule. The message to external chip designers is clear: Intel can offer a stable, multi-year roadmap.

Intel at a turning point? This analysis reveals what investors need to know now.

The stock still trades 38 percent above its 200-day average of 58.62 euros, indicating the broader recovery path remains intact despite the sharp correction. The RSI of 41.6 points to a consolidation phase following the June peak of 124.58 euros, which marked the 52-week high. Analysts currently see a mean price target of roughly 100 euros — implying upside of more than 20 percent from current levels.

The bull case now hinges on two deliverables: stable yields on 18A without costly rework, and execution on the accelerated 14A roadmap without further strain on the capital structure. The second half of 2026 will reveal whether this manufacturing pivot becomes a profitable foundry with multiple anchor tenants — or whether Intel continues to build primarily for itself. A marquee customer on 18A or 14A would do more to settle that question than any number of older-node wins. Until then, the market's skepticism is not a failure of the strategy; it is a demand for evidence.

Ad

Intel Stock: New Analysis - 31 July

Fresh Intel information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Intel analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US4581401001 | INTELS | boerse | 69905639 |